AF
IBRX icon

Allworth Financial’s ImmunityBio IBRX Stock Holding History

Allworth Financial’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.62K Sell
985
-391
-28% -$2.96K ﹤0.01% 3810
2026
Q1 		$10.6K Buy
1,376
+73
+6% +$500 ﹤0.01% 3460
2025
Q4 		$2.58K Sell
1,303
-146
-10% -$331 ﹤0.01% 4023
2025
Q3 		$3.56K Buy
1,449
+556
+62% +$1.43K ﹤0.01% 3726
2025
Q2 		$2.36K Buy
893
+788
+750% +$2.12K ﹤0.01% 3631
2025
Q1 		$283 Buy
+105
New +$318 ﹤0.01% 3808

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allworth Financial's IBRX Position: Q2 2026 in Review

Allworth Financial reduced its ImmunityBio (IBRX) stake by 28% in Q2 2026, selling an estimated $2.96K and leaving 985 shares worth $8.62K. The position accounts for ﹤0.01% of the portfolio, ranked #3810.

Allworth Financial first reported a position in IBRX in Q1 2025 and has held it in 6 quarters since. The position peaked at $10.6K in Q1 2026. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Allworth Financial held 985 shares of ImmunityBio worth $8.62K as of Q2 2026.
  • Allworth Financial sold 391 ImmunityBio shares in Q2 2026, an estimated $2.96K.
  • ImmunityBio made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3810 holding.
  • Allworth Financial first reported a position in ImmunityBio in Q1 2025 and has held it in 6 quarters since.
  • Allworth Financial's ImmunityBio position peaked at $10.6K in Q1 2026.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.